| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |